Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Nov 15;280(Pt 1):199–204. doi: 10.1042/bj2800199

Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.

J Jones 1, B P Morgan 1
PMCID: PMC1130620  PMID: 1741748

Abstract

Different cell types vary widely in their susceptibility to killing by the pore-forming cytolytic molecule perforin. In particular, the cells responsible for synthesis of perforin, i.e. cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, are very resistant to cytolysis by this molecule. It has previously been suggested that resistance is due, at least in part, to diminished binding of perforin to these cells. The purpose of the present study was to compare binding of perforin to sensitive and resistant cell types. To this end, perforin was biosynthetically labelled prior to purification. The purified labelled protein was then utilized to obtain a direct measure of the amount of perforin bound to cells during attack. Resistant cells (CTL, neutrophils) bound at least as much perforin as did sensitive cells (K562, HL60 etc.), indicating that resistance to perforin involves mechanisms operating after binding of the lytic molecule.

Full text

PDF
199

Images in this article

201Fig. 1.
on p.201
202Fig. 2.
on p.202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell A. K., Morgan B. P. Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack. Nature. 1985 Sep 12;317(6033):164–166. doi: 10.1038/317164a0. [DOI] [PubMed] [Google Scholar]
  2. Henkart P. A. Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 1985;3:31–58. doi: 10.1146/annurev.iy.03.040185.000335. [DOI] [PubMed] [Google Scholar]
  3. Ishiura S., Matsuda K., Koizumi H., Tsukahara T., Arahata K., Sugita H. Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte. Mol Immunol. 1990 Aug;27(8):803–807. doi: 10.1016/0161-5890(90)90090-m. [DOI] [PubMed] [Google Scholar]
  4. Jiang S. B., Ojcius D. M., Persechini P. M., Young J. D. Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins. J Immunol. 1990 Feb 1;144(3):998–1003. [PubMed] [Google Scholar]
  5. Jiang S. B., Ojcius D. M., Young J. D. Perforin binding to cells and lipid membranes determined by a simple competition assay. J Immunol Methods. 1990 Jan 24;126(1):29–37. doi: 10.1016/0022-1759(90)90008-j. [DOI] [PubMed] [Google Scholar]
  6. Jiang S. B., Persechini P. M., Zychlinsky A., Liu C. C., Perussia B., Young J. D. Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction. J Exp Med. 1988 Dec 1;168(6):2207–2219. doi: 10.1084/jem.168.6.2207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jones J., Hallett M. B., Morgan B. P. Reversible cell damage by T-cell perforins. Calcium influx and propidium iodide uptake into K562 cells in the absence of lysis. Biochem J. 1990 Apr 15;267(2):303–307. doi: 10.1042/bj2670303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kawasaki A., Shinkai Y., Kuwana Y., Furuya A., Iigo Y., Hanai N., Itoh S., Yagita H., Okumura K. Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. Int Immunol. 1990;2(7):677–684. doi: 10.1093/intimm/2.7.677. [DOI] [PubMed] [Google Scholar]
  9. Lichtenheld M. G., Olsen K. J., Lu P., Lowrey D. M., Hameed A., Hengartner H., Podack E. R. Structure and function of human perforin. Nature. 1988 Sep 29;335(6189):448–451. doi: 10.1038/335448a0. [DOI] [PubMed] [Google Scholar]
  10. Lowrey D. M., Aebischer T., Olsen K., Lichtenheld M., Rupp F., Hengartner H., Podack E. R. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci U S A. 1989 Jan;86(1):247–251. doi: 10.1073/pnas.86.1.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Masson D., Tschopp J. Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J Biol Chem. 1985 Aug 5;260(16):9069–9072. [PubMed] [Google Scholar]
  12. Meri S., Morgan B. P., Wing M., Jones J., Davies A., Podack E., Lachmann P. J. Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis. J Exp Med. 1990 Jul 1;172(1):367–370. doi: 10.1084/jem.172.1.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Morgan B. P., Campbell A. K. The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium. Biochem J. 1985 Oct 1;231(1):205–208. doi: 10.1042/bj2310205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morgan B. P. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J. 1989 Nov 15;264(1):1–14. doi: 10.1042/bj2640001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morgan B. P., Dankert J. R., Esser A. F. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J Immunol. 1987 Jan 1;138(1):246–253. [PubMed] [Google Scholar]
  16. Ojcius D. M., Young J. D. Characterization of the inhibitory effect of lysolipids on perforin-mediated hemolysis. Mol Immunol. 1990 Mar;27(3):257–261. doi: 10.1016/0161-5890(90)90138-p. [DOI] [PubMed] [Google Scholar]
  17. Podack E. R., Young J. D., Cohn Z. A. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8629–8633. doi: 10.1073/pnas.82.24.8629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rollins S. A., Sims P. J. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol. 1990 May 1;144(9):3478–3483. [PubMed] [Google Scholar]
  19. Scolding N. J., Jones J., Compston D. A., Morgan B. P. Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology. 1990 May;70(1):6–10. [PMC free article] [PubMed] [Google Scholar]
  20. Stein J. M., Luzio J. P. Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles. Biochem J. 1991 Mar 1;274(Pt 2):381–386. doi: 10.1042/bj2740381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Young J. D., Cohn Z. A., Podack E. R. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. Science. 1986 Jul 11;233(4760):184–190. doi: 10.1126/science.2425429. [DOI] [PubMed] [Google Scholar]
  22. Young J. D., Damiano A., DiNome M. A., Leong L. G., Cohn Z. A. Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin). J Exp Med. 1987 May 1;165(5):1371–1382. doi: 10.1084/jem.165.5.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Young J. D., Hengartner H., Podack E. R., Cohn Z. A. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell. 1986 Mar 28;44(6):849–859. doi: 10.1016/0092-8674(86)90007-3. [DOI] [PubMed] [Google Scholar]
  24. Young J. D., Leong L. G., Liu C. C., Damiano A., Cohn Z. A. Extracellular release of lymphocyte cytolytic pore-forming protein (perforin) after ionophore stimulation. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5668–5672. doi: 10.1073/pnas.83.15.5668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Young J. D., Liu C. C. How do cytotoxic T lymphocytes avoid self-lysis? Immunol Today. 1988 Jan;9(1):14–15. doi: 10.1016/0167-5699(88)91349-7. [DOI] [PubMed] [Google Scholar]
  26. Zalman L. S., Wood L. M., Müller-Eberhard H. J. Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes. J Exp Med. 1987 Oct 1;166(4):947–955. doi: 10.1084/jem.166.4.947. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES